Teva Pharmaceutical (TEVA) Enters Into a License Agreement With Prestige Biopharma for the Commercialization of Tuznue in Europe

24 10 月, 2025

One Min Read

6 Views

原文: https://finance.yahoo.com/news/teva-pharmaceutical-teva-enters-license-114207968.html

Last Update: 24 10 月, 2025

Written By

Other Articles

Previous

Canaccord Genuity Reiterates a Buy Rating on Kenvue Inc. (KVUE)

Next

JPMorgan Maintains an Overweight Rating on Ford Motor Company (F)

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept